Does Incobotulinumtoxina Interact with Botulinum Toxin Type A?
CDI records a major classification for Incobotulinumtoxina and Botulinum Toxin Type A. The stored summary is: Administration of different botulinum toxin products at the same time or within several months may exacerbate excessive neuromuscular weakness. The mechanism involves additive neuromuscular effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Incobotulinumtoxina Class
- Acetylcholine Release Inhibitor
- Botulinum Toxin Type A Class
- Acetylcholine Release Inhibitor
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Additive neuromuscular effects
What To Tell Your Doctor or Pharmacist
If you are taking Incobotulinumtoxina and your doctor is considering prescribing Botulinum Toxin Type A (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider